Pharmacotherapy for Fragile X Syndrome: Progress to Date.
about
Modeling Fragile X Syndrome Using Human Pluripotent Stem CellsFragile X syndrome: a review of clinical and molecular diagnoses.Updated report on tools to measure outcomes of clinical trials in fragile X syndrome.Fragile X targeted pharmacotherapy: lessons learned and future directions.Imbalance between Glutamate and GABA in Fmr1 Knockout Astrocytes Influences Neuronal Development.Fragile X syndrome: an overview and update of the FMR1 gene.Molecular biomarkers predictive of sertraline treatment response in young children with fragile X syndrome.Roles for Arc in metabotropic glutamate receptor-dependent LTD and synapse elimination: Implications in health and disease.A New Link Between Insulin Signaling and Fragile X Syndrome.
P2860
Q28080022-2489018C-D35A-476F-843A-3A09BA30FFD6Q33576328-32EAC15D-6D3C-4ABF-8CF2-5D50C7701C04Q33785978-23F51689-047F-48C2-8C09-596342CE3EB1Q33785983-21D20A5A-5B3A-4472-A565-ED6DE7780F99Q37208978-D4CA985E-AE40-4D55-B677-F7BA38A1D544Q39375765-21A6AADE-14C3-4896-A827-1FC9EDCD9E3EQ46227616-D0092C21-36AE-4075-9FF8-C40FA7A20B02Q47752204-345E895D-A64E-40FF-BBF1-38241E384357Q48431901-600DABD3-401E-4617-960C-6CCAB0C022FD
P2860
Pharmacotherapy for Fragile X Syndrome: Progress to Date.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Pharmacotherapy for Fragile X Syndrome: Progress to Date.
@en
type
label
Pharmacotherapy for Fragile X Syndrome: Progress to Date.
@en
prefLabel
Pharmacotherapy for Fragile X Syndrome: Progress to Date.
@en
P2093
P2860
P1433
P1476
Pharmacotherapy for Fragile X Syndrome: Progress to Date
@en
P2093
Craig A Erickson
Katherine J Friedmann
Matthew H Davenport
Tori L Schaefer
P2860
P2888
P304
P356
10.1007/S40265-016-0542-Y
P577
2016-03-01T00:00:00Z
P6179
1005001296